Correlation Between Sera Prognostics and BioAffinity Technologies,
Can any of the company-specific risk be diversified away by investing in both Sera Prognostics and BioAffinity Technologies, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sera Prognostics and BioAffinity Technologies, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sera Prognostics and bioAffinity Technologies,, you can compare the effects of market volatilities on Sera Prognostics and BioAffinity Technologies, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sera Prognostics with a short position of BioAffinity Technologies,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sera Prognostics and BioAffinity Technologies,.
Diversification Opportunities for Sera Prognostics and BioAffinity Technologies,
0.31 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Sera and BioAffinity is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Sera Prognostics and bioAffinity Technologies, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on bioAffinity Technologies, and Sera Prognostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sera Prognostics are associated (or correlated) with BioAffinity Technologies,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of bioAffinity Technologies, has no effect on the direction of Sera Prognostics i.e., Sera Prognostics and BioAffinity Technologies, go up and down completely randomly.
Pair Corralation between Sera Prognostics and BioAffinity Technologies,
Given the investment horizon of 90 days Sera Prognostics is expected to generate 1.27 times more return on investment than BioAffinity Technologies,. However, Sera Prognostics is 1.27 times more volatile than bioAffinity Technologies,. It trades about 0.07 of its potential returns per unit of risk. bioAffinity Technologies, is currently generating about 0.01 per unit of risk. If you would invest 125.00 in Sera Prognostics on August 26, 2024 and sell it today you would earn a total of 529.00 from holding Sera Prognostics or generate 423.2% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sera Prognostics vs. bioAffinity Technologies,
Performance |
| Timeline |
| Sera Prognostics |
| bioAffinity Technologies, |
Sera Prognostics and BioAffinity Technologies, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sera Prognostics and BioAffinity Technologies,
The main advantage of trading using opposite Sera Prognostics and BioAffinity Technologies, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sera Prognostics position performs unexpectedly, BioAffinity Technologies, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioAffinity Technologies, will offset losses from the drop in BioAffinity Technologies,'s long position.| Sera Prognostics vs. Fonar | Sera Prognostics vs. Burning Rock Biotech | Sera Prognostics vs. Exagen Inc | Sera Prognostics vs. Sotera Health Co |
| BioAffinity Technologies, vs. Eliem Therapeutics | BioAffinity Technologies, vs. HCW Biologics | BioAffinity Technologies, vs. Scpharmaceuticals | BioAffinity Technologies, vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |